Penn Medicine shared a post on X:
“A new NEJM Evidence study found racial disparities among patients treated with CART-cell therapy for lymphoma.
Marco Ruella is working with Carmen Guerra to find why disparities exist to ensure all patients can benefit from the transformative therapy.”
Additional information.
Source: Penn Medicine/X